203 related articles for article (PubMed ID: 22405837)
1. Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3'-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells.
Li X; Lee SO; Safe S
Biochem Pharmacol; 2012 May; 83(10):1445-55. PubMed ID: 22405837
[TBL] [Abstract][Full Text] [Related]
2. Structure-dependent activation of gene expression by bis-indole and quinoline-derived activators of nuclear receptor 4A2.
Li X; Tjalkens RB; Shrestha R; Safe S
Chem Biol Drug Des; 2019 Oct; 94(4):1711-1720. PubMed ID: 31102570
[TBL] [Abstract][Full Text] [Related]
3. Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands.
Upadhyay S; Hailemariam AE; Mariyam F; Hafiz Z; Martin G; Kothari J; Farkas E; Sivaram G; Bell L; Tjalkens R; Safe S
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540704
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of skin cancer with 1,1-Bis (3'-indolyl)-1-(aromatic) methane analog through induction of the orphan nuclear receptor, NR4A2 (Nurr1).
Boakye CH; Doddapaneni R; Shah PP; Patel AR; Godugu C; Safe S; Katiyar SK; Singh M
PLoS One; 2013; 8(8):e69519. PubMed ID: 23950896
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma-dependent activity of indole ring-substituted 1,1-bis(3'-indolyl)-1-(p-biphenyl)methanes in cancer cells.
Guo J; Chintharlapalli S; Lee SO; Cho SD; Lei P; Papineni S; Safe S
Cancer Chemother Pharmacol; 2010 May; 66(1):141-50. PubMed ID: 19823826
[TBL] [Abstract][Full Text] [Related]
6. 1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth.
Inamoto T; Papineni S; Chintharlapalli S; Cho SD; Safe S; Kamat AM
Mol Cancer Ther; 2008 Dec; 7(12):3825-33. PubMed ID: 19074857
[TBL] [Abstract][Full Text] [Related]
7. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.
Lei P; Abdelrahim M; Cho SD; Liu S; Chintharlapalli S; Safe S
Carcinogenesis; 2008 Jun; 29(6):1139-47. PubMed ID: 18460448
[TBL] [Abstract][Full Text] [Related]
8. Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3'-indoly)-1-(p-substituted phenyl)methanes.
Lei P; Abdelrahim M; Cho SD; Liu X; Safe S
Mol Cancer Ther; 2008 Oct; 7(10):3363-72. PubMed ID: 18852139
[TBL] [Abstract][Full Text] [Related]
9. The Nurr1 Activator 1,1-Bis(3'-Indolyl)-1-(p-Chlorophenyl)Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κB.
De Miranda BR; Popichak KA; Hammond SL; Jorgensen BA; Phillips AT; Safe S; Tjalkens RB
Mol Pharmacol; 2015 Jun; 87(6):1021-34. PubMed ID: 25858541
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma.
Zarei M; Shrestha R; Johnson S; Yu Z; Karki K; Vaziri-Gohar A; Epps J; Du H; Suva L; Zarei M; Safe S
Cancer Res Commun; 2021 Nov; 1(2):65-78. PubMed ID: 35582016
[TBL] [Abstract][Full Text] [Related]
11. Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas.
Karki K; Li X; Jin UH; Mohankumar K; Zarei M; Michelhaugh SK; Mittal S; Tjalkens R; Safe S
J Neurooncol; 2020 Jan; 146(1):25-39. PubMed ID: 31754919
[TBL] [Abstract][Full Text] [Related]
12. A novel diindolylmethane analog, 1,1-bis(3'-indolyl)-1-(p-chlorophenyl) methane, inhibits the tumor necrosis factor-induced inflammatory response in primary murine synovial fibroblasts through a Nurr1-dependent mechanism.
Afzali MF; Popichak KA; Burton LH; Klochak AL; Wilson WJ; Safe S; Tjalkens RB; Legare ME
Mol Immunol; 2018 Sep; 101():46-54. PubMed ID: 29870816
[TBL] [Abstract][Full Text] [Related]
13. 1,1-Bis(3'-indolyl)-1-(p-bromophenyl)methane and related compounds repress survivin and decrease gamma-radiation-induced survivin in colon and pancreatic cancer cells.
Sreevalsan S; Jutooru I; Chadalapaka G; Walker M; Safe S
Int J Oncol; 2009 Nov; 35(5):1191-9. PubMed ID: 19787275
[TBL] [Abstract][Full Text] [Related]
14. A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro.
Hammond SL; Safe S; Tjalkens RB
Neurosci Lett; 2015 Oct; 607():83-89. PubMed ID: 26383113
[TBL] [Abstract][Full Text] [Related]
15. Potent synthetic and endogenous ligands for the adopted orphan nuclear receptor Nurr1.
Jang Y; Kim W; Leblanc P; Kim CH; Kim KS
Exp Mol Med; 2021 Jan; 53(1):19-29. PubMed ID: 33479411
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.
Hedrick E; Li X; Cheng Y; Lacey A; Mohankumar K; Zarei M; Safe S
Breast Cancer Res Treat; 2019 Aug; 177(1):29-40. PubMed ID: 31119568
[TBL] [Abstract][Full Text] [Related]
17. Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.
De Miranda BR; Popichak KA; Hammond SL; Miller JA; Safe S; Tjalkens RB
Toxicol Sci; 2015 Feb; 143(2):360-73. PubMed ID: 25406165
[TBL] [Abstract][Full Text] [Related]
18. Lethal Factor Domain-Mediated Delivery of Nurr1 Transcription Factor Enhances Tyrosine Hydroxylase Activity and Protects from Neurotoxin-Induced Degeneration of Dopaminergic Cells.
Paliga D; Raudzus F; Leppla SH; Heumann R; Neumann S
Mol Neurobiol; 2019 May; 56(5):3393-3403. PubMed ID: 30121937
[TBL] [Abstract][Full Text] [Related]
19. A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.
Qin C; Morrow D; Stewart J; Spencer K; Porter W; Smith R; Phillips T; Abdelrahim M; Samudio I; Safe S
Mol Cancer Ther; 2004 Mar; 3(3):247-60. PubMed ID: 15026545
[TBL] [Abstract][Full Text] [Related]
20. Natural products and synthetic analogs as selective orphan nuclear receptor 4A (NR4A) modulators.
Safe S
Histol Histopathol; 2024 May; 39(5):543-556. PubMed ID: 38116863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
